Embryonic stem cell markers Nanog, Oct-4, and SOX-2, the cancer stem cell marker CD133, and the leukemia stem cell marker (CD123) [19] were examined (Fig 5, S1 and S2 Dataset). This evidence concerns the gene SOX2 and leukemia.